Skip to main content

1620 INVESTMENT ADVISORS, INC.

Position in PFE — Pfizer Inc

CIK 1907281 PLYMOUTH, MA

Position in PFE

as of Jun 30, 2026 · filed Jul 14, 2026
Position Value
$869,288
-$162,315 QoQ
Shares Held
36,100
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
#1,409
of 2,821 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 50% Shared 0% None 50%

Common Shares in PFE Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $6,968,762 across 10 Drug Manufacturers - General names. PFE ranks #4 (12.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 PFE
Pfizer Inc
This page
36,100 $869,288

All Filings in PFE

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $869,288 36,100
2026-03-31 $1,031,603 36,738
2025-12-31 $905,538 36,367
2025-09-30 $1,031,048 40,465
2025-06-30 $926,840 38,236
2025-03-31 $474,364 18,720
2024-12-31 $479,954 18,091
2024-09-30 $555,184 19,184
2024-06-30 $540,825 19,329
2024-03-31 $21,783 785
2023-12-31 $535,666 18,606
2023-09-30 $606,878 18,296
2023-06-30 $670,877 18,290
2023-03-31 $738,520 18,101
2022-12-31 $926,163 18,075
2022-09-30 $786,410 17,971
2022-06-30 $934,669 17,827
2022-03-31 $895,724 17,302
2021-12-31 $1,021,683 17,302